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ORIGINAL RESEARCH
Objective: To establish the effectiveness of EEG biofeedback using beta training as a
relaxation technique and ultimately reducing anxiety levels of patients with confirmed unstable
angina or myocardial infarction.
Methodology: Patients with confirmed unstable angina or myocardial infarction referred by
cardiologists were recruited 2–3 days after their cardiac event from the cardiology wards.
Their initial anxiety scores were determined using the Hospital Anxiety and Depression Scale.
Those that returned for therapy underwent instrument feedback training using EEG every two
weeks for a total of five sessions. EEG frequencies were measured for all sessions. Dropouts
who did not participate in the program agreed to return 3 months later for the second
psychological assessment. The study design was uncontrolled.
Results: Subjects had significantly lower anxiety scores at the second screening (p < 0.001),
while the dropouts had significantly higher scores (p < 0.001). Beta training was effective in
increasing sensory motor rhythm (SMR) waves but no significant effect was present for the
alpha waves.
Conclusions: The uncontrolled nature of the study limits firm conclusions. However, the
significantly lowered anxiety scores for subjects and enhancing of SMR waves indicate the
effectiveness of beta training as a promising approach to EEG biofeedback for anxiety
reduction.
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Introduction
Appropriate breathing and relaxation techniques decrease the morbidity and mortality
of patients with cardiac events especially myocardial infarction (Dixhorn and
Duivenvoordeen 1999). Incorporating these stress reduction therapies in the usage
of EEG biofeedback proves to be an important entity in cardiac rehabilitation programs
involving patients with ischemic heart diseases. EEG biofeedback might benefit
patients with cardiac events as it is associated with the central nervous system and
reduces anxiety. Anxiety aggravates the heart condition of patients with coronary
heart disease through sympathetic nervous system hyperactivity, increased heart rate,
diminished autonomic control of the heart, and increased blood pressure variability,
which eventually affects coronary endothelium and plaque formation (King
1997). The present study aims to discover the effectiveness of EEG biofeedback in
influencing brainwaves by looking at the EEG frequencies and the distribution of
alpha and beta waves during therapy as well as its capability to decrease anxiety
levels after five concurrent sessions.
EEG biofeedback, or as its more commonly known, neurofeedback, has shown
much clinical value in treating neurobiological disorders such as epilepsy (Kotchoubey
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et al 1999), attention deficit hyperactivity disorder
(Masterpasqua and Healey 2003), and substance abuse
(Peniston and Kulkosky 1989). Research shows that a
number of these neurological and psychological disorders
can be characterized by distinctive EEG patterns and that
neurofeedback may help clients change their patterns
(Masterpasqua and Healey 2003). However, studies have
also focused on healthy individuals as EEG biofeedback,
like mental skills training and aerobic exercise, was able to
improve the performance of musicians (Egner and Gruzelier
2003).
Neurofeedback refers to an operant conditioning
paradigm where participants learn to influence the electrical
activity of their brain by regulating specific AC frequencies
and the slow cortical potentials (SCPs) of the EEG (Vernon
et al 2003). The electrical brain activity is used to control a
computer, and this type of communication is usually called
a brain-computer interface (Neuper et al 2003). Theta
training was traditionally viewed as forming part of a
relaxation inducing technique and was originally associated
with meditation (Kassamatao and Hirai 1969). However,
this form of training requires participants to relax with their
eyes closed, receiving only auditory feedback. The most
common indicators of relaxation are an increase in alpha
frequencies and less complexity in EEG signals, and this
establishes the positive effect of a mind machine (Stolc et
al 2003). This study utilizes the less frequent beta training
and its capability to bring about a mental state of brain
relaxation as effective as the alpha and theta bands.
Methodology
Participants
Patients with confirmed unstable angina or myocardial
infarction referred by the cardiologists were recruited 2–3
days after their cardiac event from the cardiology wards,
National University of Malaysia Hospital (HUKM) and the
Institut Jantung Negara (IJN). A cardiac event was based
on typical clinical symptomatology, identified through ECG
evidence and elevated serum levels of myocardial enzymes.
These patients were entered into the study irrespective of
age, sex, or ethnicity. All patients were given full details of
the study at recruitment and were invited to participate.
Written consent was obtained.
Psychological assessment
The Hospital Anxiety and Depression Scale (HADS) was
administered at initial diagnosis of cardiac events and during
follow-up three months later. The cut-off point indicates
the range from normal to severe. The normal rate is below
8, while 8–10 indicates mild symptoms, 11–14 moderate
symptoms, and a range of 15–21 points to a severe state of
anxiety. For this study, severity of anxiety was limited to
three groups, normal and severe representing both extremes,
while mild and moderate were categorized as one level. The
questionnaire was interview-aided and not self-rated, and
only one interviewer conducted the questionnaire for all
subjects to avoid interviewer bias. It was not a single-blind
study as the interviewer was aware of the treatment
conditions. Anxiety levels were used in this study to
determine the effectiveness of the therapy. The HADS was
chosen due to its practicality and expediency (Roberts et al
2001). Its most important feature was its capability to
produce a separate score to establish the presence and
severity of anxiety and depression simultaneously. The
HADS was also practical in this study as the sample size
was small and the scale was validated for use in non-
psychiatric units, thus making it an acceptable instrument
for cardiac patients.
EEG biofeedback training
Participants who returned for therapy received instrument
feedback involving beta/sensory motor rhythms (SMR)
training using commercially available biofeedback
equipment (Procomp+/Biograph programme-Thought
Technology Ltd, Montreal, QC, Canada) every two weeks
for a total of 5 sessions. The biofeedback instrumentation
provided a media of transferring information from these
brainwaves. It worked on a reward basis in which positive
feedback resulted in accumulated points, and negative
feedback resulted in these points being withheld. A computer
monitor was placed 150 cm from the patient. Both the visual
feedback received through a video game-like display
portraying a maze animation and audio feedback with the
inclusion of music with changes in frequency, volume, and
rhythm enabled the individual to respond by moving toward
a better, learned, and voluntary-controlled function as they
consciously directed their brainwaves. For feedback con-
trol, there were 3 bargraphs; beta (16–40 Hz), theta
(4–7 Hz), and EEG (1–40 Hz). Bars were dark when the
signal was within acceptable parameters and turned a bright
color when they were not, to rapidly indicate which
condition was not satisfied. When the beta signal was above
threshold, the animation started and a song played while
the counter accumulated points. When any of the threeNeuropsychiatric Disease and Treatment 2005:1(4) 359
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signals got out of condition (beta below threshold, theta, or
EEG [1–40 Hz] were above threshold), the animation and
music stopped. The animation instrument comprising a maze
was linked to this beta instrument.
EEG was recorded from channel C3 according to the
International 10–20 system for all training. The reference
electrode was placed at the left ear lobe and ground electrode
at the right ear lobe. The system applied a variety of digital
filters to the recorded signal to extract frequency-domain
information. The subsets of the whole EEG bandwidth were
filtered and the real-time changes in the total power
generated by all the frequencies in the subsets were
measured. Frequencies above 40 Hz were interpreted as
EMG noise from the neighboring muscles. The component
brainwaves of the EEG were separated into individual bands
with alpha band defined as 8–12 Hz. Beta waves were
categorized into low beta or sensory motor rhythm, SMR
(12–15 Hz), beta (16–20 Hz), and high beta (21–40 Hz).
Minimal configuration for monochannel EEG measurement
consisted of 1 active electrode.
Procedure
Subjects received continuous feedback involving a
completion of five sessions of EEG biofeedback training in
the three months duration. The workings of the feedback
loop were explained to all participants before the start of
sessions and they were required to relax without falling
asleep. In the training sessions, they were instructed on ways
of improving their positive feedback and taught simple
breathing exercises to use. Subjects were also required to
practice the relevant relaxation and breathing exercises that
provided positive feedback daily, preferably at a fixed time
of day. The subjects underwent the whole length of the
experiment period in a quiet but not a soundproof area, with
no one present except for the examiner, and these conditions
were preserved for all subjects as described by Teplan
(2002). Changes in the EEG frequencies were measured by
use of a task that required participants to sustain the 3 bar
graphs displayed within the expected parameters described
in the above section titled EEG biofeedback training. The
first session and the last session were assessed to compare
the progress made by the participants at the end of the
therapy with the time of recruitment. Mean frequencies were
compared for the entire session for the first and last session
each participant underwent. Those that dropped out earlier
did not receive any therapy. Anxiety levels for all patients
(subjects and dropouts) were determined twice, once at time
of recruitment (first screening) and at the follow-up
assessment three months later (second screening). Within-
group and between-group statistical comparisons were made
using Student’s t-test.
Results
Characteristics of the sample
population
All 115 patients recruited into the study went through an
initial psychological assessment in the first screening. Fifty
(43%) of them returned to participate in the EEG bio-
feedback therapy. Four percent completed only 3 sessions,
and 20% completed 4. The remainder (n = 38, 76%)
completed the required number of 5 sessions. Mean time of
completion for sessions was 7.20 minutes, with times
ranging from 3.01 to 14.27 minutes. Forty-three percent of
the sessions were completed within 5 minutes, with 55%
exceeding 5 minutes. Only 2 sessions were completed in less
than 5 minutes, with one taking 3 minutes and the other 4.
The remaining 65 patients that declined to participate in
the program agreed to be reevaluated for the follow-up
psychological assessment during the second screening. For
the purpose of this paper, the first group of 65 patients that
dropped out without any EEG biofeedback intervention will
be identified as dropouts. The patients that consented to the
therapy will be considered as subjects, with those
successfully completing all 5 sessions as subjects 1, and
those that dropped out after going through at least 3 sessions
of EEG biofeedback sessions as subjects 2 (n = 12). Most
of the subjects (subjects 1 and subjects 2) were male (68%),
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Figure 1 Percentage of patients with different levels of severity for anxiety.
Levels of severity for anxiety based on Hospital Anxiety and Depression Scale.
First screening is during recruitment; second screening is at follow-up
assessment 3 months later. Subjects (n = 50) are those that consented to
participate in the EEG biofeedback. Thirty-eight of the subjects completed all 5
sessions, and 12 of them dropped out after 3 or 4 sessions. Dropouts (n = 65)
declined to participate in the therapy but agreed to be psychologically assessed.Neuropsychiatric Disease and Treatment 2005:1(4) 360
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while dropouts had an almost equal distribution of both
sexes; males (n = 30, 46%) and females (n = 35, 53%).
Anxiety levels
Most patients (subjects and dropouts) had normal anxiety
levels (71%) at initial recruitment. Thirty-four (68%) of the
subjects and 73% of the dropouts had normal levels of
anxiety scores at first assessment (Figure 1). There was no
difference for anxiety scores between subjects and dropouts
for the first screening, but dropouts had significantly higher
scores compared with subjects at the second screening
(p < 0.001). At completion of therapy, subjects had
significantly (p < 0.001) lower mean anxiety scores than at
screening, while dropouts had significantly (p < 0.001)
higher mean anxiety scores at second than at first screening.
The dropouts had more than half of those cases (n = 28,
58%) with initial normal range of scores and more than half
of the initial mild to severe cases (n = 9, 53%) recording
higher scores for the second screening, respectively
(Table 1). A mere 14% of the dropouts decreased their
anxiety scores. Neither of the subject groups (subjects 1
and subjects 2) had a single case that had increased anxiety
scores for the second assessment. More than half of subjects
1 with normal anxiety levels in first screening (n = 16, 59%)
decreased their scores while the remainder maintained their
scores. Almost half of subjects 1 who initially scored in the
mild to severe range lowered their scores (Table 1). Four of
the 5 mild to severe cases in the subjects 2 decreased their
scores. Mean and maximum value for subjects 2 with initial
normal scores succeeded in decreasing their mean and
maximum scores but not their maximum value (Table 2).
Those who scored mild to severe levels of anxiety scores
for dropouts and the subject groups all managed to decrease
their minimum scores, but the most drastic change was for
Table 1 Changes in anxiety scores at second screening as compared with the first screening in subjects 1, subjects 2, and
dropouts
Patients recruited (n = 115)
Consented to treatment (n = 50)
Completed 5 session Completed < 5 sessions Declined treatment
Subjects 1
a Subjects 2
b Dropouts
c
(n = 38) (n = 12) (n = 65)
Initial anxiety levels (based on anxiety scores at first screening)d
Normal Mild to severe Normal Mild to severe Normal Mild to severe
(n = 27) (n = 11) (n = 7) (n = 5) (n = 48) (n = 17)
Changes in anxiety scores at second screening as compared with first screening
↓ No ↓ No ↓ No ↓ No ↓ No ↑↓ No ↑
n 1 6 1 15 63 44 15 1 5 2 84 4 9
a Subjects 1: patients recruited that returned to participate in the therapy and successfully completed all 5 required sessions.
b Subjects 2: patients recruited that returned to participate in the therapy and completed at least 3 sessions but not all of the 5 required sessions.
c Dropouts: patients recruited that did not return to participate in the therapy although agreed to be assessed for the follow-up psychological assessment at second
screening.
d Anxiety levels: normal range (< 8) and mild to severe (≥ 8).
NOTE: ↓, those that decreased levels of anxiety scores; No, those with no changes in their anxiety scores; ↑, those that had increased levels of anxiety scores.
Table 2 Anxiety scores for subjects 1, subjects 2, and dropouts for first and second screening
Patients recruited (n = 115)
Initial anxiety levels (based on anxiety scores at first screening)
Normal (n = 82) Mild to severe (n = 33)
Dropouts
a Subjects 1
b  Subjects 2
c Dropouts Subjects 1 Subjects 2
(n = 48) (n = 27) (n = 7) (n = 17) (n = 11) (n = 5)
Screening 1st 2nd 1st 2nd 1st 2nd 1st 2nd 1st 2nd 1st 2nd
Anxiety scores
Mean 4 5 4 2 4 3 11 11 10 8 13 10
Minimum 0 1 0 0 1 0 8 5 8 0 8 6
Maximum 7 12 7 6 6 6 15 15 19 15 19 15
a Dropouts: patients recruited that did not return to participate in the therapy although agreed to be assessed for the follow-up psychological assessment at second
screening.
b Subjects 1: patients recruited that returned to participate in the therapy and successfully completed all 5 required sessions.
c Subjects 2: patients recruited that returned to participate in the therapy and completed at least 3 sessions but not all of the 5 required sessions.Neuropsychiatric Disease and Treatment 2005:1(4) 361
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subjects 1 that had a minimum score of 0 as compared with
8 in the first screening.
EEG frequencies for alpha and beta
waves
To describe the performance over the training period, the
online results of training sessions were shown as mean
frequencies of both alpha and beta waves. Nineteen (70%)
of the subjects that scored normal scores had high initial
alpha waves for the first and last sessions. The normal initial
scorers maintained their high alpha frequencies in the last
session and those that did not have high initial frequencies
were still unable to increase their frequencies. Nevertheless,
73% of those that scored mild to severe anxiety levels in
the first screening also had high initial alpha waves.
Furthermore, these participants had 1 person for subjects 1
and 2 persons for subjects 2 that succeeded in increasing
their alpha frequencies by their final session (Table 3).
None of the subjects recorded high beta waves and
instead most had very low beta frequencies of SMR. A mere
6 participants of subjects 1 with normal levels of anxiety
scores recorded moderate levels of beta waves (16–40 Hz)
at their first session. Nevertheless, 5 of the subjects 1 group
and 1 of the subjects 2 group managed to increase beta waves
from low frequency SMR waves to moderate beta
frequencies. Three of the subjects 1 group with initial mild
to severe anxiety scores increased their SMR waves to the
preferred beta frequencies. All of these 3 lowered their
anxiety scores to normal levels by the second assessment.
Discussion
As anxiety remains prevalent in patients after their cardiac
events (Goodacre et al 2001), progress was indicated in the
participants by their significantly reduced anxiety scores
after five sessions of beta training. The ability to generate
alpha brainwaves has been associated with the self-
regulation of stress (Wacker 1996). Previous studies
specifically linked anxiety and relaxation with EEG
recordings (Isotani et al 2001) and found that an increase in
alpha frequencies in the frontal scalp area is an indication
of positive relaxation training effects of audiovisual
stimulation (Teplan et al 2003) and is neuroprotective
(Sterman et al 1970).
As a whole, most participants had normal anxiety levels
and this probably had some effect on the results of the EEG
recordings particularly the alpha waves. Although alpha
changes are tightly linked to anxiety changes, this is only
evident in high-anxiety subjects as discovered by Hardt and
Kamiya (1978). Their study showed that some people with
high levels of anxiety have low alpha waves, and EEG alpha
increase is beneficial only for patients who exhibit this low
amplitude alpha. Patients with anxiety who show abnormally
Table 3 EEG frequencies for alpha and beta waves in subjects 1 and subjects 2 for the first and last session
Patients consented to treatment (n = 50)
Initial anxiety levels (based on anxiety scores at first screening)
a
Normal Mild to severe
(n = 34) (n = 16)
Subjects 1
b Subjects 2
c Subjects 1 Subjects 2
(n = 27) (n = 7) (n = 11) (n = 5)
Session 1st last 1st last 1st last 1st last
Alpha frequencies
(≥ 8 Hz), n 19 19 4 4 8 9 2 3
AMF, Hz
Mean 12.8 15.5 10.3 14.2 16.1 21.5 7.8 9.0
Minimum 4.8 5.1 4.1 5.0 2.5 7.2 6.4 7.7
Maximum 27.2 28.9 24.5 26.8 27.3 28.9 8.7 11.0
Beta frequencies
(16–40 Hz), n 6 11 1 2 5 8 – –
BMF, Hz
Mean 8.8 10.9 7.1 9.8 11.6 14.7 4.5 5.3
Minimum 3.5 3.7 2.3 4.1 2.2 4.2 4.1 4.5
Maximum 19.3 20.1 17.6 19.6 19.3 19.2 4.7 6.5
a Anxiety levels: normal ranges (< 8) and mild–severe (≥ 8).
b Subjects 1: patients recruited that returned to participate in the therapy and successfully completed all 5 required sessions.
c Subjects 2: patients recruited that returned to participate in the therapy and completed at least 3 sessions but not all of the 5 required sessions.
NOTE: Dashes denote data are not suitable for beta frequencies.
Abbreviations: AMF, mean alpha frequencies; BMF, mean beta frequencies.Neuropsychiatric Disease and Treatment 2005:1(4) 362
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high levels of alpha at baseline readings do not respond as
effectively to alpha increase biofeedback. Another important
factor is that alpha waves attenuation is no longer evident
with open eyes (Nakagome 2000), and our subjects were
instructed to keep their eyes open throughout their sessions.
Another study also found no stimulation on the alpha band
for participants that were asked to remain awake but with
their eyes closed (Schutter et al 2001).
Generally, patients undergoing beta training would have
initial high beta frequencies of 22–40 Hz to be used for
baseline comparisons. However, the beta bands for all our
subjects during the recruitment stage were in the low SMR
frequencies, which were below normal beta frequencies.
This also suggests that these participants were not highly
stressed at the initial diagnosis of their cardiac event during
recruitment as excessive beta waves are associated with
anxiety (Kiloh et al 1981).
The significant difference in the mean anxiety scores
between the participants and the control group for the second
assessment suggests that EEG biofeedback can effectively
lower mild to moderate levels of anxiety, thus making it
ideal to be used in nonpsychiatric units, ie, cardiac settings.
Biofeedback as a low arousal training methodology has been
previously efficient in treating anxiety disorders (Rice et al
1993). Inconsistencies in the different studies concerning
anxiety reduction could be attributed to the way anxiety
was assessed in individual patients and the actual length of
treatment with longer periods of treatment reducing anxiety
more effectively.
Detailed evaluation of each patient undergoing treatment
would be a better evaluation of the characteristics and
efficiency of the treatment. The Biograph program used for
our study only required an electrode to be placed on only
one active site in the scalp (C3) for EEG recordings. Most
of the other similar studies recorded EEG from more than
one active site according to the International 10–20 system.
Furthermore, any increase in arousal affects the EEG
frequencies in the entire region of the scalp and not just an
isolated area (Barry et al 2004). Changes in arousal levels
are linked with global activity while specific regional activity
is linked with processing. A comprehensive EEG recording
from the global activity might give more details on the effect
of EEG beta waves training on anxiety levels.
Although we used an open and uncontrolled design, our
study has a reasonably large sample size compared with
some previous neurotherapy studies (Tebecis et al 1976;
Bird et al 1978; Lubar JO and Lubar JF 1984; Wacker 1996;
Miner et al 1998; Kim et al 2002), all of which had less
than 20 participants. Nevertheless, criticisms of the small
number of subjects have resulted in bigger sample sizes for
more recent studies (Kaiser and Othmer 2000; Putnam 2000;
Joyce and Siever 2001).
While the number of subjects participating was
sufficient, the initial high dropout rate makes it difficult to
conduct a double-blind study in which the one group of
subjects are randomly assigned to EEG biofeedback and
the other group to another type of biofeedback. Nevertheless,
our study of 5 sessions of operant training of EEG activity
was sufficient to produce significant changes in anxiety
scores. Even in the subjects 2 group, those that dropped out
by the third or fourth session were able to reduce their
anxiety scores. A more detailed assessment would be to see
the long-term effect of therapy, and evaluate whether a
3-month program could still have positive influence on
anxiety 6 months or one year after completion of treatment.
Clinical implications
EEG biofeedback using beta training appeared useful in the
treatment of anxiety based on the psychological assessment.
Even so, the absence of significant associations between
anxiety scores and EEG frequencies for either alpha or beta
waves suggests that the improvement may be due to a
placebo effect (Passini et al 1977). Although training
involving EEG activation must be within a consistent therapy
situation (Rosenfeld et al 1996), it is difficult to distinguish
the effects of EEG training from confounding conditions
like drowsiness, medications, caffeinated drinks, changes
in emotional state/arousal, artifact from eye movements,
time of day, and state of alertness. Therefore, these factors
should be taken into consideration to eliminate the
possibility of their influence on the positive effects resulting
from intervention.
Nevertheless, EEG biofeedback provides accumulated
benefits for some participants. The learning gained by the
subjects during their training can be applied in their everyday
life, as participants had their eyes open and learnt to stay
relaxed while remaining alert and reducing their tendency
to fall asleep. Biofeedback may also indirectly assist the
participant to be better focused, more in control, and to feel
clinically better.
The open and uncontrolled nature of our study militates
against firm conclusions. However, the significant reduction
in anxiety scores could lead to a big improvement in the
morbidity and mortality rate of these patients as a further
reduction was seen even in those scoring normal level scoresNeuropsychiatric Disease and Treatment 2005:1(4) 363
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during initial recruitment. The increase in SMR waves by
the end of the therapy suggested a higher level of
concentration and alertness for participants as they
underwent their relaxation and biofeedback therapy. This
was evident in another study which showed that enhancing
SMR frequencies into a relaxed state had been linked with
significant behavioral and cognitive changes (Ramirez et al
2001). Further research, however, is warranted to evaluate
beta training as an effective EEG biofeedback in producing
positive results as an adjunct technique to improve the
various relaxation techniques. In summary, beta training
could be proposed as a promising approach.
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